The UK government has announced an indefinite ban on prescribing puberty blockers to minors for gender dysphoria, citing safety concerns. Health Secretary Wes Streeting emphasized the need for caution and announced plans for a clinical trial to evaluate the drugs' long-term effects, with a review set for 2027.